4//SEC Filing
CORRIGAN MARK 4
Accession 0001104659-18-030626
CIK 0001641640other
Filed
May 3, 8:00 PM ET
Accepted
May 4, 4:03 PM ET
Size
5.2 KB
Accession
0001104659-18-030626
Insider Transaction Report
Form 4
CORRIGAN MARK
Director
Transactions
- Award
Stock Option
2018-05-02+29,000→ 29,000 totalExp: 2028-05-02→ Ordinary Shares (29,000 underlying)
Footnotes (2)
- [F1]The exercise price is $4.91 per share.
- [F2]This option was granted on May 2, 2018. Vesting began on May 2, 2018 and ends on May 2, 2019. One hundred percent (100%) of the option will vest on May 2, 2019.
Documents
Issuer
Nabriva Therapeutics plc
CIK 0001641640
Entity typeother
Related Parties
1- filerCIK 0001250661
Filing Metadata
- Form type
- 4
- Filed
- May 3, 8:00 PM ET
- Accepted
- May 4, 4:03 PM ET
- Size
- 5.2 KB